Basic Information
Basic information for FTX-225-12aa-2
Peptide Name FTX-225-12aa-2
Genome Position chrX:74004843-74004878[-]
Species Human
Peptide Sequence MPVFTAISKHKL
Peptide Length 12
Unique No (AC068587.4-204-12aa-1,FTX-213-12aa-1,FTX-214-12aa-2,FTX-215-12aa-2,FTX-217-12aa-1,FTX-220-12aa-1,STPG2-AS1-202-12aa-2,FTX-226-12aa-1,FTX-256-12aa-2,AC083864.5-201-12aa-2,AC244636.3-201-12aa)
Grand Average of Hydropathicity 0.4083
Relative Molecular Mass 1569.9
Experimental Evidences no
lncRNA ID/Name ENSG00000230590;FTX
Transcript ID/Name ENST00000652071;FTX-225
Transcript Length 1964
Coding Ability 0.2739
DNA Sequence Corresponding to Peptide ATGCCTGTCTTTACTGCAATCTCTAAACATAAATTG
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :